Navigation Links
Keystone Symposia announces new 3-year grant to tackle major global health challenges
Date:7/19/2012

SILVERTHORNE, CO July 19, 2012 Keystone Symposia on Molecular and Cellular Biology is pleased to announce that it has received a fourth grant from the Bill & Melinda Gates Foundation to promote discoveries that will solve urgent global health problems via support of infectious disease conferences in the "Keystone Symposia Global Health Series." The grant also funds Global Health Travel Awards for investigators from developing countries, a pre-meeting workshop for Travel Awardees, and registration costs for local participants at the conferences that are based in developing countries.

A Colorado, USA-based nonprofit organization, Keystone Symposia received three previous grants from the Foundation, beginning in 2004 and ending with the December 2012 conference on "Immunological Mechanisms of Vaccination" in Ottawa, Ontario, Canada, which will be held following the conclusion of the Grand Challenges meeting for that program's grantees. Keystone Symposia typically holds one Global Health Series conference each year in conjunction with the Grand Challenges meeting.

The new grant will provide support for conferences in 2013, 2014 and 2015. It consists of $2.25 million in funding over three years or $750,000 per year.

The five 2012-2013 season Keystone Symposia conferences funded by the new grant are: "Malaria" in New Orleans, Louisiana, USA in January 2013; "HIV Vaccines" in Keystone, Colorado, USA in February 2013; "Tuberculosis: Understanding the Enemy" in Whistler, British Columbia, Canada in March 2013; "Immune Activation in HIV Infection: Basic Mechanisms and Clinical Implications" in Breckenridge, Colorado, USA in April 2013 and "The Innate Immune Response in the Pathogenesis of Infectious Disease" in Ouro Preto, Brazil in May 2013. The latter will be the first conference for Keystone Symposia in Latin America.

More than half of the grant is used to fund Global Health Travel Awards for investigators, clinicians, graduate students and postdoctoral fellows from developing countries where the health issues of the meeting topic are endemic. Without these awards, these individuals would not be able to attend the conferences and participate in the valuable knowledge-sharing and collaboration-building that result. To date, more than 1,100 individuals from at least 50 countries have participated in Keystone Symposia conferences as a result of Global Health Travel Awards.

A unique component of the Global Health Series meetings that the funding also supports is a pre-meeting workshop for Travel Awardees in which three to four speakers provide an overview of the field, its current status and primary challenges. This has proved enormously valuable to participants who may be more involved in field work and therefore not as close to the latest research.

The grant will also help fund some registration costs for local scientists, postdoctoral associates and students when the conferences are held in developing countries. This promotes sharing of the latest research advances with those on the frontlines of battling global health challenges. It also stimulates growth of the research enterprise in developing countries.

James Aiken, Chief Executive Officer of Keystone Symposia, expressed his deep appreciation for the grant: "The support from the Foundation is an essential base that we build upon to expand our global science educational activities and to enhance science capability worldwide."

Added Dr. David Woodland, Keystone Symposia's Chief Scientific Officer, "This partnership with the Bill and Melinda Gates Foundation promotes global scientific collaboration, elevates scientific capability in the developing world and accelerates the discovery of solutions to critical infectious disease problems, such as malaria, tuberculosis and AIDS. A prominent feature of the Global Health Series is also to expose talented young trainees from around the world to cutting-edge infectious disease research with a view to developing the next generation of scientists that will tackle global health problems."


'/>"/>

Contact: Yvonne Psaila
yvonnep@keystonesymposia.org
970-262-2676
Keystone Symposia on Molecular & Cellular Biology
Source:Eurekalert

Related medicine news :

1. Elsevier announces publishing the Journal of Hospitality, Leisure, Sport and Tourism Education
2. MindSpec announces Bridging Parents with Autism Science webinar series
3. Heuer M.D. Research Announces CardiaShred™ - First Medical Doctor Formulated, Heart Healthy Weight Loss, Energy and Lean Muscle Building Supplement
4. Somers Orthopaedic Surgery & Sports Medicine Group, PLLC Announces the Opening of their New Physical Therapy Location at its Hopewell Junction Office
5. PMIC Announces Release of New CDT 2013 Dental Procedure Coding System
6. LWW announces 57% growth in 2011 impact factor rankings
7. Coral Calcium Company Announces New Offer Amidst Supreme Court Healthcare Decisions
8. As New Premature Ejaculation Drugs Get Closer To The Public Market, LastLonger2Night.com Announces A Drug-Free Solution
9. Content Writing King Announces Cancellation Of Experimental Video Creation Process For Their Article Marketing Website
10. DeNova Homes at Southgate, Announces Single Story Model Opening
11. Nurse Alert Senior Medical Alert System Announces Solution for Seniors to Help Reduce Medical Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: